Document is current
Any future updates will be listed below
-
Authors
Costa, Ines PD
Schiano, Guglielmo
Sacnun, Juan Manuel
Herzog, Rebecca
Kerr, Alastair
Dahlman, Ingrid
Delporte, Christine
Kratochwill, Klaus
Devuyst, Olivier
-
Funding
Funding for this research was provided by:
HORIZON EUROPE Marie Sklodowska-Curie Actions (812699, 812699)
Austrian Science Fund (Elise Richter V907-B)
- License Information
-
More Information
Article History
Received: 5 May 2025
Accepted: 16 September 2025
First Online: 7 November 2025
Competing interests
: J.M.S., R.H., and K.K. are former PhD students or employees, or current consultants of Zytoprotec, a spin-off of the Medical University of Vienna holding the patent “Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue” (International Publication Number: WO 2008/106702 A1) and the use-patent “Peritoneal dialysis fluid comprising a GSK-3 inhibitor”. K.K. is co-founder of Delta 4, a start-up focusing on computational drug repurposing. The remaining authors declare no competing interests.
